Research in the Hoggatt Lab
Over the past several decades, translational research has focused largely on finding “magic bullets”: a small molecule or perhaps protein biologic that can be given to the patient as a drug to cure their disease. We believe that the cures of the future will come instead from tapping in to the body’s natural regenerative capacities or will use cellular therapies, specifically stem cell transplantation.
Our goals are to discover new regenerative pathways within the body to allow for disease correction and to make stem cell transplantation faster, safer, cheaper and better to broaden its use to more patients.
Jon Hoggatt holds appointments in both the Cancer Center and Center for Transplantation Sciences, and is a principal faculty member of the Harvard Stem Cell Institute.
Jon obtained his PhD from Indiana University School of Medicine in 2010, where his dissertation was recognized as the most outstanding amongst all disciplines and awarded the Esther L. Kinsley award. He then completed a post-doctoral fellowship with David Scadden at Harvard University, where he received an HSCI T32 training award, and an NIH Pathway to Independence award.
Jon’s work has focused on translational science in bone marrow transplantation, and has resulted in several clinical trials and high profile papers in Nature, Nature Medicine, and others. During his graduate studies, Jon served as a Police Commissioner and then later as a City Councilman for West Lafayette, Indiana. He serves the American Society of Hematology on the Government Affairs and Communications Committees and is a Contributing Editor of The Hematologist.